Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
A narrative review synthesizing mechanistic and clinical evidence on three supplements for insulin resistance, concluding they should be adjuncts to lifestyle and standard therapy in selected patients, pending future RCTs.
A narrative review synthesizing preclinical and limited clinical evidence; concludes CBD is biologically plausible but clinically unproven, with no consistent human data supporting efficacy for insulin sensitivity or muscle function.